The Congo Ebola outbreak continued to spread six months into the response, the Africa Centres for Disease Control and Prevention (Africa CDC) and United Nations agencies said on November 15, 2026. They called for safe access to communities where conflict has blocked access in the Democratic Republic of the Congo.
The agencies said the virus was spreading more slowly in some early hot spots. But attacks and the flight of people from their homes put those gains at risk. Their figures show the toll so far and the pace of new cases.
| Measure | Reported figure |
|---|---|
| Cases since the outbreak began | More than 11,000 |
| Deaths since the outbreak began | 5,400 |
| New cases reported per week | 400–500 |
| Geographic spread | 67 health zones in eight provinces |
Source: Africa CDC and UN agencies via UNICEF
Transmission continued across eight provinces despite progress in the initial outbreak centers.
Access gaps in the Congo Ebola outbreak
The joint statement said teams lost contact with more than 1,000 people exposed to Ebola after an attack in Cantine-Aloya. Teams could not account for three patients with confirmed Ebola. Three health facilities had been looted. The agencies called for the fighting to stop.
Doctors Without Borders, also known as MSF, describes gaps beyond the threat of attacks. Its teams have found ambulances without fuel, unpaid staff and community workers without phones to send alerts. In Ituri, just 9% of Ebola patients treated by its teams were already on lists of known contacts.
MSF said the Congolese government had announced steps to track how response funds are spent. The group also noted gains in testing and care. But it called for more aid to reach places still being missed.
Why tracing contacts matters
For teams working on the Congo Ebola outbreak, finding contacts is a key step. The World Health Organization (WHO) says signs of illness can take two to 21 days to appear after infection. Its guidance says teams watch the health of known contacts for 21 days after exposure. As a result, teams can spot illness and get people tested and treated.
Its disease guidance says Ebola spreads mainly through contact with infected blood or other body fluids. This includes fluids from people who have died. Objects soiled with these fluids can also spread the virus. People giving care face higher risks without the right protection.
The same guidance notes that early signs can look like malaria or other illnesses. So a lab test is needed to confirm Ebola. Early care helps people survive and slows the spread of disease. That makes prompt care and testing key parts of the response.
Why an Ebola vaccine is still being tested
WHO says Bundibugyo virus caused this outbreak. It is one of several different viruses that cause Ebola disease. Ervebo, the licensed Ebola vaccine, works against a different virus, previously called Zaire ebolavirus. But that does not prove it works against Bundibugyo.
The agency says there is still too little evidence to know whether Ervebo protects people against Bundibugyo disease. There is no licensed vaccine for this disease. It recommends using Ervebo within studies to find out.
Its vaccine guidance describes how the Tumaini clinical trial is studying that question. It uses ring vaccination. Teams find people who have had contact with an infected person and give vaccines within those groups. In this way, the trial tests whether the vaccine works in people at higher risk.
The agency’s trial update also names two proposed vaccines designed for Bundibugyo: ChAdOx1, developed by Oxford with the Serum Institute of India, and Moderna’s mRNA-1469. They will join following national approvals. Both still need testing. Neither is a proven way to stop this outbreak.
The update puts expected vaccine trial results in early 2027. Meanwhile, the joint Africa CDC and UN statement calls for funding through 2027, safe access and support for affected communities.
Sources: UNICEF joint statement, MSF, WHO disease guidance, WHO vaccine guidance, WHO trial update
